Aprin Pharmed




[68Ga] -RM2 is a potent gastrin-releasing peptide receptor (GRP-R) antagonist for prostate and breast cancer imaging and it is currently being evaluated clinically in a number of specialist facilities worldwide.

Gastrin-releasing peptide receptor (GRP-R) is a G protein-coupled receptor of the bombesin receptor family that shows great potential for imaging and treatment of many cancers.

CAS registration number
  • -
Molecular weight
  • 1625.87 g/mol
molecular formula
  • C77H116N20O19
  • Solid powder
  • Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Therapeutic applications
  • Positron Emission Tomography (PET) imaging or radionuclide therapy